SCHEMBL7079059

SCHEMBL7079059

COC(=O)CC(CS(=O)(=O)c1ccc(F)cc1)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
HTT P42858 2/20 0.43
MAPT P10636 1/20 0.43
LMNA P02545 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CRHBP P24387 1/20 0.42
CYP2C19 P33261 1/20 0.42
CRHR2 Q13324 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
HSD11B1 P28845 2/20 0.42
KCNA5 P22460 1/20 0.41
FNTA P49354 1/20 0.41
FNTB P49356 1/20 0.41
POLB P06746 1/20 0.41
MMP13 P45452 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7073376 0.88 ALDH1A1 (0.46) ALDH1A1KMT2AHSD11B1KCNA5MMP13
SCHEMBL7079124 0.87 ALDH1A1 (0.45) ALDH1A1MEN1KMT2ALMNANPSR1
SCHEMBL7077840 0.85 GABBR2 (0.49) ALDH1A1MAPTHSD11B1FNTAFNTB
SCHEMBL7077860 0.85 GABBR2 (0.49) ALDH1A1MAPTHSD11B1FNTAFNTB
SCHEMBL7079922 0.84 MMP2 (0.43) ALDH1A1HSD11B1KCNA5FNTAFNTB
SCHEMBL7077837 0.84 ALDH1A1 (0.45) ALDH1A1MEN1KMT2ALMNACYP3A4
SCHEMBL7075400 0.82 F2 (0.45) ALDH1A1KCNA5POLBMMP13MMP2
SCHEMBL7078814 0.82 MMP13 (0.48) ALDH1A1FNTAFNTBMMP13MMP2
SCHEMBL7073767 0.81 MMP13 (0.49) ALDH1A1MEN1KMT2ACYP2C9CYP2C19
SCHEMBL7078057 0.79 HSD11B1 (0.48) ALDH1A1MEN1KMT2AMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003059872-A1 AVB3 AND AVB5 INTEGRIN ANTAGONISTS AND METHODS OF TREATING DISEASES OR CONDITIONS ASSOCIATED WITH AVB3 AND AVB5 INTEGRINS BAYER PHARMACEUTICALS CORPORATION (US) 2003-07-24 WO disclosed